InvestorsHub Logo
Followers 1
Posts 27
Boards Moderated 0
Alias Born 02/27/2024

Re: None

Thursday, 05/02/2024 7:00:03 AM

Thursday, May 02, 2024 7:00:03 AM

Post# of 462570
The data seem to indicate a real effect, better and safer than the competition. A small effect though, and based on limited data, but probably enough to get it approved and reimbursed if everything is done in the right way. However, the constant delays, mixed messages and lack of initiatives made me concerned, as well as the very limited medical-commercial knowledge in the company. If they want to partner next steps, then that's fine, but they should not wait any longer then. At this moment a big pharma company could buy the whole business for 600M and have a blockbuster in a few years. Then most of us have lost a lot of money.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News